Beranda600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Tutup sebelumnya
¥3,84
Rentang hari
¥3,82 - ¥3,87
Rentang tahun
¥2,83 - ¥4,97
Kapitalisasi pasar
9,67 M CNY
Volume Rata-Rata
49,65 jt
Rasio P/E
14,62
Hasil dividen
-
Bursa utama
SHA
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 4,17 M | 0,78% |
Biaya operasional | 844,30 jt | -9,24% |
Laba bersih | 212,93 jt | 20,48% |
Margin laba bersih | 5,10 | 19,44% |
Penghasilan per saham | — | — |
EBITDA | 322,56 jt | 3,64% |
Tarif pajak efektif | 19,49% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,80 M | -1,58% |
Total aset | 14,09 M | -0,38% |
Total liabilitas | 7,79 M | -8,76% |
Total ekuitas | 6,31 M | — |
Saham yang beredar | 2,52 M | — |
Harga terhadap nilai buku | 1,74 | — |
Tingkat pengembalian aset | 4,68% | — |
Tingkat pengembalian modal | 8,65% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 212,93 jt | 20,48% |
Kas dari operasi | -464,57 jt | -71,56% |
Kas dari investasi | -17,57 jt | -19,17% |
Kas dari pembiayaan | -271,12 jt | -314,72% |
Perubahan kas bersih | -753,69 jt | -372,72% |
Arus kas bebas | -538,39 jt | -13,57% |
Tentang
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Didirikan
1988
Situs
Karyawan
10.180
